TherapeuticsMD, Inc. (TXMD): Form 8-K filed 2026-11-13
- Accepted by EDGAR
- 2026-11-13 16:05 ET
- Event date
- 2026-11-13
- Accession no.
- 0001213900-26-119681
- Original filing
- SEC EDGAR filing index
AI summary of the filing text. It can contain mistakes; the original filing is authoritative.
TherapeuticsMD reports third quarter 2026 financial results
TherapeuticsMD reported third quarter 2026 net income from continuing operations of $501 thousand, compared to $50 thousand in the third quarter of 2025. License revenue increased 60.6% to $1.3 million, primarily reflecting an IMVEXXY sales-based milestone payment. The company continues to evaluate strategic alternatives and has not established a timetable for completing the process.
- Net income from continuing operations was $501 thousand, or $0.04 per basic and diluted common share.
- License revenue rose 60.6% to $1.3 million, including a $365 thousand IMVEXXY sales-based milestone payment.
- Total operating expenses were $1.7 million, up 5.6% from the third quarter of 2025.
- Cash and cash equivalents totaled $10.4 million as of September 30, 2026.
earnings
Items reported
- Item 2.02: Results of Operations and Financial Condition
The company publicly announced results of operations or financial condition for a completed period, most often a quarterly earnings release. The release itself is usually attached as Exhibit 99.1. Information under Item 2.02 is generally "furnished" rather than "filed". - Item 7.01: Regulation FD Disclosure
The company is making information public under Regulation FD, which requires broad public disclosure of material information shared with certain market participants. Investor presentations and press releases are common. Like Item 2.02, this information is generally "furnished" rather than "filed". - Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | CURRENT REPORT | ea0312204-8k_therapeu.htm |
| EX-99.1 | PRESS RELEASE FROM THERAPEUTICSMD, INC., DATED NOVEMBER 13, 2026, ENTITLED "THER | ea031220401ex99-1.htm |
The summary above was generated by AI from the filing text and checked automatically against it. Read the original documents on SEC EDGAR. How to read an 8-K.